IT1196261B - Derivati nucleosidici e purinici 8-sostituiti - Google Patents

Derivati nucleosidici e purinici 8-sostituiti

Info

Publication number
IT1196261B
IT1196261B IT22739/84A IT2273984A IT1196261B IT 1196261 B IT1196261 B IT 1196261B IT 22739/84 A IT22739/84 A IT 22739/84A IT 2273984 A IT2273984 A IT 2273984A IT 1196261 B IT1196261 B IT 1196261B
Authority
IT
Italy
Prior art keywords
sub
derivatives
purinic
nucleosidic
substituted
Prior art date
Application number
IT22739/84A
Other languages
English (en)
Italian (it)
Other versions
IT8422739A0 (it
IT8422739A1 (it
Inventor
Silvano Casadio
Duccio Favara
Amedeo Omodei Sale
Ezio Panto'
Original Assignee
Pierrel Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierrel Spa filed Critical Pierrel Spa
Publication of IT8422739A0 publication Critical patent/IT8422739A0/it
Priority to IT22739/84A priority Critical patent/IT1196261B/it
Priority to PT81045A priority patent/PT81045B/pt
Priority to ZA857075A priority patent/ZA857075B/xx
Priority to EP85111690A priority patent/EP0175325B1/en
Priority to AT85111690T priority patent/ATE41430T1/de
Priority to DE8585111690T priority patent/DE3568783D1/de
Priority to US06/776,472 priority patent/US4774325A/en
Priority to GR852261A priority patent/GR852261B/el
Priority to DK426185A priority patent/DK167318B1/da
Priority to AU47672/85A priority patent/AU591462B2/en
Priority to CA000491088A priority patent/CA1268175A/en
Priority to NZ213550A priority patent/NZ213550A/xx
Priority to ES547856A priority patent/ES8701773A1/es
Priority to JP60208571A priority patent/JPS61112077A/ja
Priority to CN 85108905 priority patent/CN1024278C/zh
Publication of IT8422739A1 publication Critical patent/IT8422739A1/it
Application granted granted Critical
Publication of IT1196261B publication Critical patent/IT1196261B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
    • C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
    • C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
    • C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IT22739/84A 1984-09-20 1984-09-20 Derivati nucleosidici e purinici 8-sostituiti IT1196261B (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
IT22739/84A IT1196261B (it) 1984-09-20 1984-09-20 Derivati nucleosidici e purinici 8-sostituiti
PT81045A PT81045B (pt) 1984-09-20 1985-08-28 Processo para a preparacao de novos derivados do nucleosido e da purina 8-substituidos, e de composicoes farmaceuticas contendo-os
ZA857075A ZA857075B (en) 1984-09-20 1985-09-16 New 8-substituted nucleoside and purine derivatives,the process for the preparation thereof and the pharmaceutical compositions containing them
EP85111690A EP0175325B1 (en) 1984-09-20 1985-09-16 New 8-substituted nucleoside and purine derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them
AT85111690T ATE41430T1 (de) 1984-09-20 1985-09-16 8-substituierte nukleosid- und purinderivate, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen zusammensetzungen.
DE8585111690T DE3568783D1 (en) 1984-09-20 1985-09-16 New 8-substituted nucleoside and purine derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them
US06/776,472 US4774325A (en) 1984-09-20 1985-09-16 New 8-substituted nucleoside and purine derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them
GR852261A GR852261B (OSRAM) 1984-09-20 1985-09-17
DK426185A DK167318B1 (da) 1984-09-20 1985-09-19 8-substituerede puriner, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende forbindelserne
AU47672/85A AU591462B2 (en) 1984-09-20 1985-09-19 New 8-substituted nucleoside and purine derivaties, the process for the preparation thereof and the pharmaceutical compositions containing them
CA000491088A CA1268175A (en) 1984-09-20 1985-09-19 8-substituted nucleoside and purine derivatives, the process for the preparation thereof and the pharmaceutical compositions containing them
NZ213550A NZ213550A (en) 1984-09-20 1985-09-19 Purine-substituted nucleoside derivatives and pharmaceutical compositions
ES547856A ES8701773A1 (es) 1984-09-20 1985-09-20 Procedimiento de preparar derivados de nucleosidos y purinas8-substituidos
JP60208571A JPS61112077A (ja) 1984-09-20 1985-09-20 ８−置換されたヌクレオシド及びプリン誘導体
CN 85108905 CN1024278C (zh) 1984-09-20 1985-12-11 8-位上取代的核苷及嘌呤衍生物的制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22739/84A IT1196261B (it) 1984-09-20 1984-09-20 Derivati nucleosidici e purinici 8-sostituiti

Publications (3)

Publication Number Publication Date
IT8422739A0 IT8422739A0 (it) 1984-09-20
IT8422739A1 IT8422739A1 (it) 1986-03-20
IT1196261B true IT1196261B (it) 1988-11-16

Family

ID=11199882

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22739/84A IT1196261B (it) 1984-09-20 1984-09-20 Derivati nucleosidici e purinici 8-sostituiti

Country Status (14)

Country Link
US (1) US4774325A (OSRAM)
EP (1) EP0175325B1 (OSRAM)
JP (1) JPS61112077A (OSRAM)
AT (1) ATE41430T1 (OSRAM)
AU (1) AU591462B2 (OSRAM)
CA (1) CA1268175A (OSRAM)
DE (1) DE3568783D1 (OSRAM)
DK (1) DK167318B1 (OSRAM)
ES (1) ES8701773A1 (OSRAM)
GR (1) GR852261B (OSRAM)
IT (1) IT1196261B (OSRAM)
NZ (1) NZ213550A (OSRAM)
PT (1) PT81045B (OSRAM)
ZA (1) ZA857075B (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9111580D0 (en) * 1991-05-30 1991-07-24 Wellcome Found Nucleoside derivative
IT1248528B (it) * 1991-06-21 1995-01-19 Pierrel Spa Derivati di eteri e tioeteri (etero) aromatici aventi attivita` antiiperlipidemica, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
US5233041A (en) * 1991-10-07 1993-08-03 Glaxo Group Limited Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone from a 2,3-unsaturated-1-cyclopentanylpurinone
WO1994022864A1 (en) * 1993-03-30 1994-10-13 Sterling Winthrop Inc. Acyclic nucleoside analogs and oligonucleotide sequences containing them
US5329008A (en) * 1993-04-07 1994-07-12 Glaxo Inc. Synthesis of a 3,4-dihydroxy-1-cyclopentanylpurinone
US5969135A (en) * 1995-11-02 1999-10-19 Icn Pharmaceuticals, Inc. Oligonucleotide analogs with an amino acid or a modified amino alcohol residue
EP1423080A4 (en) * 2001-03-01 2009-06-03 Conforma Therapeutics Corp PROCESS FOR TREATING PROLIFERATIVE GENETIC DISORDERS WITH HSP90 INHIBITORS
EP1440072A4 (en) * 2001-10-30 2005-02-02 Conforma Therapeutic Corp PURINE ANALOGS HAVING HSP90 INHIBITORY ACTIVITY
US20070129334A1 (en) * 2001-10-30 2007-06-07 Conforma Therapeutics Corporation Orally Active Purine-Based Inhibitors of Heat Shock Protein 90
US6906190B2 (en) * 2002-01-04 2005-06-14 Ribapharm Inc. Inhibitors for de novo-RNA polymerases and methods of identifying targets for same
JP3929949B2 (ja) * 2003-08-08 2007-06-13 独立行政法人科学技術振興機構 酸化により機能性ユニットを放出するヌクレオシドおよびそれを含むオリゴヌクレオチドの製造法
NZ546611A (en) * 2003-09-18 2010-02-26 Conforma Therapeutics Corp Novel heterocyclic compounds as HSP90-inhibitors
BRPI0609509A2 (pt) * 2005-03-30 2010-04-13 Conforma Therapeutics Corp composto ou um polimorfo, solvato, tautÈmero, enanciÈmero, pró-droga ou sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso do composto, polimorfo, solvato, tautÈmero, enanciÈmero, pró-droga ou sal farmaceuticamente aceitável
US20070105874A1 (en) * 2005-09-23 2007-05-10 Conforma Therapeutics Corporation Anti-Tumor Methods Using Multi Drug Resistance Independent Synthetic HSP90 Inhibitors

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE111312C (OSRAM) * 1897-12-16
US2819260A (en) * 1953-06-04 1958-01-07 Petrolite Corp Process for preparing oxyalkylated derivatives
US3391196A (en) * 1965-08-16 1968-07-02 Wyandotte Chemicals Corp High equivalent weight hydroxy-terminated ethylene oxide-butylene oxide polyether polyols
BE738543A (OSRAM) * 1968-09-10 1970-03-09
JPS5133799B2 (OSRAM) * 1973-06-14 1976-09-21
US4048307A (en) * 1974-12-26 1977-09-13 Asahi Kasei Kogyo Kabushiki Kaisha Cyclic adenosine monophosphate 8-substituted derivatives
DE2631046A1 (de) * 1975-07-15 1977-01-20 Snam Progetti Adeninderivate und verfahren zu deren herstellung
SU883056A1 (ru) * 1980-03-26 1981-11-23 Ленинградский Ордена Ленина И Ордена Трудового Красного Знамени Государственный Университет Им.А.А.Жданова Способ получени [8-(6-аминогексил)-амино]-аденозин-5-дифосфата
DE3027279A1 (de) * 1980-07-18 1982-05-06 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Substituierte adenosin-3',5'-phosphorsaeurebenzyltriester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0045544B1 (en) * 1980-08-06 1985-03-20 Shell Internationale Researchmaatschappij B.V. Process for the manufacture of polyether polyols and their use for preparing polyurethanes
JPS6094992A (ja) * 1983-10-28 1985-05-28 Sankyo Co Ltd グリゼオ−ル酸誘導体

Also Published As

Publication number Publication date
IT8422739A0 (it) 1984-09-20
PT81045B (pt) 1987-09-18
EP0175325A2 (en) 1986-03-26
NZ213550A (en) 1989-06-28
PT81045A (en) 1985-09-01
DE3568783D1 (en) 1989-04-20
JPS61112077A (ja) 1986-05-30
ATE41430T1 (de) 1989-04-15
CA1268175A (en) 1990-04-24
AU591462B2 (en) 1989-12-07
AU4767285A (en) 1986-03-27
IT8422739A1 (it) 1986-03-20
ES8701773A1 (es) 1987-01-01
US4774325A (en) 1988-09-27
GR852261B (OSRAM) 1986-01-17
DK426185A (da) 1986-03-21
ES547856A0 (es) 1987-01-01
ZA857075B (en) 1986-06-25
JPH0569109B2 (OSRAM) 1993-09-30
DK167318B1 (da) 1993-10-11
EP0175325B1 (en) 1989-03-15
DK426185D0 (da) 1985-09-19
EP0175325A3 (en) 1987-02-04

Similar Documents

Publication Publication Date Title
IT8422739A1 (it) Nuovi derivati nucleosidici e purinici 8-sostituiti
ES8800888A1 (es) Procedimiento para la preparacion de compuestos analogos in-denicos de la mevalonolactona y sus derivados
IT1183483B (it) Derivati di 1-fluorofenilbutil-4-(2-pirimidinil)fiperazina antipsicotici
ES8306767A1 (es) "metodo de preparar compuestos esteroidicos antiinflamatorios".
IT8521865A0 (it) Derivati di etilendiamminomonoammidi.
FI812635L (fi) Piperidylidenderivat deras framstaellning och dessa innehaollande farmaceutiska blandningar
ATE53588T1 (de) Herstellung von cytosin-nukleosiden.
ATE31295T1 (de) Benzoylharnstoffderivate.
ES482420A1 (es) Un procedimiento para la preparacion de 4-desoxi-4-acilamino-derivados de eritromicilamina.
DK333785D0 (da) Mevalonolactonderivater
ES2052526T3 (es) Derivados de pirimidina, su preparacion y medicamentos que contienen estos derivados.
IT1201481B (it) Pantotenil derivati
ES2001125A6 (es) Soporte de papel impermeable al agua para capas fotograficas y procedimiento para producir el mismo
IT8248901A0 (it) Cotica, e procedimento per la loro derivati di spirotiazolidinil pipepreparazione razina dotati di attivita' antipsi-
ES509331A0 (es) Procedimiento para preparar bis- y poli-sulfuros.
MY116824A (en) Antivaral,highly water soluble,stable,crystalline salts of 2'',3''-dideoxyinosine monohydrate,2'',3''-dideoxy-2'' ,3''-didehydrothymidine monohydrate and 2'',3''-dideoxy-2''-fluoroinosine hemihydrate
ES474350A1 (es) Procedimiento para la obtencion de derivados de la tiazolina.
IT8519442A0 (it) Derivati di fenilpropargilammine
IE893533L (en) Substituted 3-aminosydnonimines, processes for their¹preparation and their use
BG49444A1 (en) Acylureidoamynotiasolylni derivatives and method for their preparation
AR241135A2 (es) "derivados de n-triazinil-n-sulfamoilurea herbicidamente activos y formulacion herbicida que los contiene".
SU1266156A1 (ru) 7-морфолинокумарины в качестве красителей для лазерной техники
SU892892A1 (ru) 3-Дицианметилпиримидо-[4,5-е][1,2,4]-триазин-6,8-дион гидрат, обладающий противовоспалительной активностью
IT1171487B (it) Derivati di diazabicicloottandioni dotati di froprieta' farmacologiche e procedimento per la loro preparazione
IT1222864B (it) Preparati cosmetici liposomiali

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950928